In a matter of weeks Presight Capital has just closed a $350 million second fund, less than two years since it annouced its first fund of $80 million. Following the great success of Presight Capital Fund I since its inception in 2019, QC·Ventures, the VC ARM of Q·Advisers, is excited to announce our continued support and participation in Presight Capital Fund II.
Presight Capital is a Venture Capital fund founded by Fabian Hansen and serial entrepreneur and investor, Christian Angermayer. The international fund takes a global approach to early-stage investments, supporting seed stage through to Series A and beyond. So far, Presight has invested in a number of cutting edge Bio Tech opportunities such as Terran Biosciences, who are developing a broad portfolio of transformative therapeutics to improve the lives of patients with neurological and psychiatric diseases, Peptilogics, a clinical-stage biotechnology company developing novel peptide therapeutics, and Enclear Therapies, who are combining Bioscience and MedTech expertise to develop life-improving treatments for patients with CNS disease.
While Presight Capital has clear focus in the Biotech space – a market valued at USD 449.06bn in 2019 with projections to grow with a CAGR of 6.84% over the next five years – the fund is not beholden to a particular investment ethos or industry. Instead, Presight Capital leverages its extensive network of strategic partners, industry experts and co-investors to determine the brightest future stars to back. Past co-investors include top-tier leading investors such as Peter Thiel, Founders Fund, Valar Ventures, Backed VC and more.
As deal-by-deal, industry agnostic investors ourselves, we appreciate the flexible mindset of Presight Capital who have adopted an opportunistic investment strategy to best take advantage of opportunities and market trends as they arise. Christian Angermayer and Fabian Hansen bring a nimble entrepreneurial energy to the VC world, and we are excited to see where Presight Capital Fund II takes us next.
About Presight Capital:
Presight Capital is the international VC founded by serial entrepreneur and investor, Christian Angermayer and Fabian Hansen. The fund takes a global approach to early-stage investment opportunities in the software, frontier tech, biotech space & beyond.